Johnson & Johnson JNJ
NYSE JNJ
$269.99 -0.22 (-0.08%)
At close: Sep 18, 2026 · 4:00 PM EDT

Johnson & Johnson (JNJ) Cash & Current Investments (2009 - 2026)

Johnson & Johnson's (JNJ) quarterly Cash & Current Investments came in at $20.8 billion in Q2 2026, up 9.95% year-over-year from $18.9 billion in Q2 2025, and down 5.86% quarter-over-quarter from $22.1 billion in Q1 2026.

Analysis

Johnson & Johnson (JNJ) Cash & Current Investments (2009 - 2026) Analysis & Trends

Johnson & Johnson has disclosed Cash & Current Investments across 18 years of filings, most recently posting $20.8 billion for Q2 2026.

  • In Q2 2026, Cash & Current Investments rose 9.95% year-over-year to $20.8 billion; the TTM figure through Jun 2026 stood at $20.8 billion (up 9.95% YoY), while the FY2025 annual figure was $20.1 billion, down 18.02% from the prior year.
  • Cash & Current Investments came in at $20.8 billion for Q2 2026 at Johnson & Johnson, down from $22.1 billion in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $38.8 billion in Q1 2025 to a low of $18.6 billion in Q3 2025.
  • Average Cash & Current Investments over 5 years is $25.6 billion, with a median of $24.5 billion recorded in 2024.
  • Year-over-year, Cash & Current Investments surged 47.92% in 2025 and slumped 43.14% in 2026.
  • Over 5 years, Cash & Current Investments stood at $34.1 billion in 2022, then tumbled by 32.72% to $22.9 billion in 2023, then gained by 6.96% to $24.5 billion in 2024, then fell by 18.02% to $20.1 billion in 2025, then rose by 3.26% to $20.8 billion in 2026.
  • Per Business Quant data, the three most recent Cash & Current Investments figures were $20.8 billion in Q2 2026, $22.1 billion in Q1 2026, and $20.1 billion in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn 20.76 Bn
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn 6.57 Bn
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn 7.14 Bn
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn 7.69 Bn
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn 11.70 Bn
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn 11.07 Bn
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn 7.38 Bn
8 Revolution Medicines 40.91 Bn 40.91 Bn - -
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn 5.10 Bn
10 Incyte 25.18 Bn 20.65 Bn 1.57 Bn 4.54 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 28, 2026 20.76 Bn
Mar 29, 2026 22.05 Bn
Dec 28, 2025 20.10 Bn
Sep 28, 2025 18.56 Bn
Jun 29, 2025 18.88 Bn
Mar 30, 2025 38.78 Bn
Dec 29, 2024 24.52 Bn
Sep 29, 2024 20.30 Bn
Jun 30, 2024 25.48 Bn
Mar 31, 2024 26.22 Bn
Dec 31, 2023 22.93 Bn
Oct 1, 2023 23.51 Bn
Jul 2, 2023 28.51 Bn
Apr 2, 2023 24.61 Bn
Jan 1, 2023 22.28 Bn
Oct 2, 2022 34.08 Bn
Jul 3, 2022 32.57 Bn
Apr 3, 2022 30.39 Bn
Jan 2, 2022 31.61 Bn
Oct 3, 2021 31.00 Bn